Découvrez les notes des analystes et les objectifs de cours (Shuttle Pharmaceuticals) de NASDAQ:SHPH sur Benzinga. Restez informé des avis et des prévisions des experts pour l'action SHPH.

Évaluations des analystes, objectifs de prix, prévision

Shuttle Pharmaceuticals

Shuttle Pharmaceuticals Holdings, Inc. - common stock

Shuttle Pharmaceuticals Holdings Inc

SIHUAN PHARM HOLDINGS GP by Sihuan Pharmaceutical Holdings Group Ltd.

Sihuan Pharmaceutical Holdings Group Ltd

SIHUAN PHARM HLDGS ADR by Sihuan Pharmaceutical Holdings Group Ltd.

Aditxt

Apollomics

AquaBounty Technologies, Inc. - Common Stock

AquaBounty Techs

Azitra

Bone Biologics

BriaCell Therapeutics

Biodexa Pharmaceuticals plc - American Depositary Shares

Biodexa Pharmaceuticals

Bio Green Med Solution, Inc. - Common Stock

Bio Green Med Solution

bioAffinity Technologies

Celularity

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics

Genprex

GRI Bio

Indaptus Therapeutics, Inc. - Common Stock

Indaptus Therapeutics

Medicus Pharma

Onconetix

Psyence Biomedical Ltd. - Ordinary Shares

Psyence Biomedical

Protagenic Therapeutics, Inc. - Common Stock

Protagenic Therapeutics

Qualigen Therapeutics, Inc. - Common Stock

Qualigen Therapeutics

Revelation Biosciences, Inc. - Common Stock

Revelation Biosciences

Sunshine Biopharma

Scinai Immunotherapeutics Ltd. - American Depositary Shares

Scinai Immunotherapeutics

Salarius Pharmaceuticals, Inc. - Common Stock

Salarius Pharmaceuticals

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

Prévisions Shuttle Pharmaceuticals (SHPH)

Actualités

Gains

Transactions internes

Intérêt court

Rapport sur les stocks

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.

Comments

Shuttle Pharmaceuticals Évaluations des analystes

Évaluations des analystes, objectifs de prix, prévision

Notes d'analystes pour Shuttle Pharmaceuticals

FAQ

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL